Amendment No. 1 Agreement Sample Contracts
Execution Copy AMENDMENT NO. 1 AGREEMENT to the Amended and Restated License Agreement dated 26 September 2003 between Elan Corporation, plc and Acorda Therapeutics, Inc. and to the Supply Agreement dated 26 September 2003 between Elan Corporation,...Amendment No. 1 Agreement • May 5th, 2020 • New York
This AMENDMENT NO. 1 AGREEMENT and CONSENT TO SUBLICENSE (the “Amendment and Consent Agreement”) dated as of the 30th day of June, 2009 (the “Effective Date”) is by and among Elan Pharma International Limited, a company incorporated under the laws of Ireland and having its registered office at Monksland, Athlone, County Westmeath, Ireland (“Elan”), Acorda Therapeutics, Inc., a Delaware corporation with an office at 15 Skyline Drive, Hawthorne, New York 10532, USA (“Acorda”), and Biogen Idec International GmbH , a Swiss company with an office at Landis & Gyr Strasse 3, CH-6300 Zug, Switzerland (“Biogen”). Elan, Acorda and Biogen are each a “Party” and collectively, the “Parties”.